The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
There are lipidologists, in particular, who are proliferating, fortunately. There's a lot of lipid education going on, and the people that are really skilled and understand lipid metabolism are at least thinking about lipoprotein particles, not necessarily yet about sub-fractions, but at least a particle versus the LDL cholesterol is taking you in the right direction, because that's really the first step in terms of narrowing down the focus on what you should be treating.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.